Wu C, Li X, Liu S, Yao L, He T, Wang Y
iScience. 2024; 27(12):111224.
PMID: 39618499
PMC: 11607599.
DOI: 10.1016/j.isci.2024.111224.
Ithimakin S, Luengwatthanakit N, Wongkraisri C
Asian Pac J Cancer Prev. 2023; 24(4):1359-1366.
PMID: 37116159
PMC: 10352744.
DOI: 10.31557/APJCP.2023.24.4.1359.
Inoue Y, Fujishima M, Ono M, Masuda J, Ozaki Y, Maeda T
Breast Cancer Res Treat. 2022; 196(2):341-348.
PMID: 36153381
PMC: 9581831.
DOI: 10.1007/s10549-022-06726-w.
Khan S, Schuetz S, Hosseini O
Ann Surg Oncol. 2022; 29(9):5811-5820.
PMID: 35608802
DOI: 10.1245/s10434-022-11900-x.
La Rocca E, De Santis M, Silvestri M, Ortolan E, Valenti M, Folli S
J Cancer Res Clin Oncol. 2022; 148(6):1543-1550.
PMID: 35396978
PMC: 9114063.
DOI: 10.1007/s00432-022-03990-7.
Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients.
Morales-Orue I, Zafra-Martin J, Garcia L, Chicas-Sett R, Castilla-Martinez J, Cabezon M
Transl Cancer Res. 2022; 9(Suppl 1):S197-S206.
PMID: 35117963
PMC: 8797947.
DOI: 10.21037/tcr.2019.08.29.
Surgical therapy for pulmonary metastasis of breast cancer.
Soh J, Komoike Y, Mitsudomi T
Transl Cancer Res. 2022; 9(8):5044-5052.
PMID: 35117870
PMC: 8798234.
DOI: 10.21037/tcr.2020.03.63.
Metastatic breast cancer: Who benefits from surgery?.
Marks C, Thomas S, Fayanju O, DiLalla G, Sammons S, Hwang E
Am J Surg. 2021; 223(1):81-93.
PMID: 34325907
PMC: 8688223.
DOI: 10.1016/j.amjsurg.2021.07.018.
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Lacaze J, Aziza R, Chira C, De Maio E, Izar F, Jouve E
Breast. 2021; 59:144-156.
PMID: 34252822
PMC: 8441842.
DOI: 10.1016/j.breast.2021.06.010.
Caregiver burden and associated factors amongst carers of women with advanced breast cancer attending a radiation oncology clinic in Nigeria.
Jite I, Adetunji A, Folasire A, Akinyemi J, Bello S
Afr J Prim Health Care Fam Med. 2021; 13(1):e1-e8.
PMID: 34212738
PMC: 8252173.
DOI: 10.4102/phcfm.v13i1.2812.
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
Lopez-Tarruella S, Escudero M, Pollan M, Martin M, Jara C, Bermejo B
Sci Rep. 2019; 9(1):20081.
PMID: 31882586
PMC: 6934456.
DOI: 10.1038/s41598-019-55765-9.
Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer.
Quyyumi F, Wright J, Accordino M, Buono D, Law C, Hillyer G
J Oncol Pract. 2018; 15(1):e1-e9.
PMID: 30407882
PMC: 6519720.
DOI: 10.1200/JOP.18.00229.
Salvage radiotherapy for second oligo-recurrence in patients with breast cancer.
Miyata M, Ohguri T, Yahara K, Yamaguchi S, Imada H, Korogi Y
J Radiat Res. 2017; 59(1):58-66.
PMID: 29182763
PMC: 5778500.
DOI: 10.1093/jrr/rrx066.
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y
BMC Cancer. 2017; 17(1):160.
PMID: 28241804
PMC: 5330119.
DOI: 10.1186/s12885-017-3154-3.
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.
DAvino C, Palmieri D, Braddom A, Zanesi N, James C, Cole S
Oncotarget. 2016; 7(52):87016-87030.
PMID: 27894092
PMC: 5349967.
DOI: 10.18632/oncotarget.13522.
Maspin Gene Expression in Invasive Ductal Carcinoma of Breast.
Dabiri S, Moeini Aghtaei M, Shahryari J, Shamis Meymandi M, Amirpour-Rostami S, Foutohi Ardekani R
Iran J Pathol. 2016; 11(2):104-11.
PMID: 27499770
PMC: 4939639.
Follow-up strategies for women treated for early breast cancer.
Moschetti I, Cinquini M, Lambertini M, Levaggi A, Liberati A
Cochrane Database Syst Rev. 2016; (5):CD001768.
PMID: 27230946
PMC: 7073405.
DOI: 10.1002/14651858.CD001768.pub3.
Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report.
Lv X, He J, Shen Y, Zheng H
Mol Clin Oncol. 2016; 4(5):855-858.
PMID: 27123295
PMC: 4840524.
DOI: 10.3892/mco.2016.798.
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
Bishop A, Ensor J, Moulder S, Shaitelman S, Edson M, Whitman G
Cancer. 2015; 121(24):4324-32.
PMID: 26348887
PMC: 4825322.
DOI: 10.1002/cncr.29681.
Defining the survival benchmark for breast cancer patients with systemic relapse.
Zeichner S, Ambros T, Zaravinos J, Montero A, Mahtani R, Ahn E
Breast Cancer (Auckl). 2015; 9:9-17.
PMID: 25922577
PMC: 4401244.
DOI: 10.4137/BCBCR.S23794.
